Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Advisorshares Psychedelics ETF (NY: PSIL ) 0.8660 -0.0490 (-5.36%) Official Closing Price Updated: 8:00 PM EDT, Aug 28, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 56,346 Open 0.9002 Bid (Size) 0.9173 (4) Ask (Size) 1.000 (1) Prev. Close 0.9150 Today's Range 0.8600 - 0.9040 52wk Range 0.8550 - 1.870 Shares Outstanding 58,000 Dividend Yield 0.35% Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Top And Flop ETFs Of The First Half June 29, 2024 In this article, we have highlighted three ETFs each from the best and worst-performing zones in the first half of 2024. Via Talk Markets Topics ETFs Best And Worst ETF Zones Of Q2 June 26, 2024 After the worst monthly decline in many months in April, global stock markets have staged a nice comeback on renewed Fed rate cut bets, ongoing artificial intelligence (AI) developments and strong... Via Talk Markets Topics Artificial Intelligence ETFs Economy Exposures Artificial Intelligence Interest Rates Performance YTD -40.68% -40.68% 1 Month -21.27% -21.27% 3 Month -27.83% -27.83% 6 Month -41.88% -41.88% 1 Year -47.83% -47.83% More News Read More Psychedelic Stocks Trip Up After FDA Advisors Reject MDMA For PTSD Treatment June 05, 2024 Via Benzinga Exposures Product Safety Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More April 17, 2024 Via Benzinga Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's Influence March 29, 2024 Via Benzinga Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More March 20, 2024 Via Benzinga Topics Economy Exposures Interest Rates Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More March 04, 2024 Via Benzinga Mental Health Mavericks: 3 Stocks Changing the Game February 21, 2024 Via InvestorPlace Psyched: Psychedelics & Sex, MDMA And Federal Approval, Canadians For End-Of-Life Care And More February 15, 2024 Via Benzinga Psyched: Suggestibility And Psychedelics' Effects, EU's $7M Research Fund, Australia's Treatment Delivery, BZ Podcast And More January 27, 2024 Via Benzinga Psyched: $100M For MDMA Therapy, VA Funds, 2024 Watchlist, Reform Updates And More January 12, 2024 Via Benzinga Psyched: Ibogaine For TBI, Kentucky Initiative Stalled, DEA Quotas, Insurance Codes, Atai's $50M And More January 07, 2024 Via Benzinga Psyched: Biden Approves Psychedelics Trials, RFK, Australia's First Legal Dedicated Clinic & More December 27, 2023 Via Benzinga Psychedelic Drug Stocks Index Up In December; Down YTD December 27, 2023 Via Talk Markets Psyched: Biden's Big Decision On Psychedelics Therapy; LSD Anxiety Results; Matthew Perry Autopsy And More December 18, 2023 Via Benzinga Psychedelic Drug Stocks Index Declined 1.6% This Week December 17, 2023 Via Talk Markets Topics ETFs Psyched: John Lennon Remembered, Clinical Trials For Service Members, Chrissy Teigen, Jon Feliciano And More December 11, 2023 Via Benzinga 5 Largest Psychedelic Compound-Based Drug Stocks Up 3% Last Week December 10, 2023 Via Talk Markets Psyched: Defense Dept.'s Ketamine Trial, Cybin's Psilocybin, Metabolic Disorders, Reform Update And More December 05, 2023 Via Benzinga Psyched: Ramaswamy Psychedelics For PTSD, UK Clinical Trials, Johns Hopkins Q&A And More November 24, 2023 Via Benzinga Topics Cannabis Exposures Cannabis GH Research Drags Down Psychedelic Drug Stocks Index By 7% November 23, 2023 Via Talk Markets Psyched: Veterans & Psychedelics, $100M IPO, Cybin's $64M Offering, Worldwide Events & More November 12, 2023 Via Benzinga Topics Initial Public Offering Exposures Securities Market Psyched: DEA's Denial Overruled, Fed Psychedelics Change, Psilocybin For Depression, States Reform & More November 06, 2023 Via Benzinga Topics Economy Exposures Interest Rates Psyched: Cybin's Center Stage In Novel Psychedelics, Musk & Ramaswamy, Britney's Memoirs And More October 29, 2023 Via Benzinga Topics Intellectual Property Exposures Intellectual Property Psyched: Jada Pinkett-Smith's Ayahuasca Journey, RIP Dr. Roland Griffiths, Congressional VA Hearings Halted October 22, 2023 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
